NCT07611435

Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-09-15Est. Completion: 2031-10-30

Enrollment target: 160 participants

Locations

Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock, Arkansas, United States
North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill, North Carolina, United States
Vanderbilt University Medical Center: Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Nashville, Tennessee, United States
University of Virginia Health System: Division of Asthma & Immunology, Charlottesville, Virginia, United States

Alpha-Gal SyndromeIrritable Bowel SyndromeDiarrheaAbdominal PainVomiting

This is a double-blind, crossover food challenge study using pork with and without α-gal in patients with a clinical dia…

Chapel Hill, United StatesCompleted Jun 2, 2026

Clonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with susp…

Birmingham, United StatesEst. completion Jul 31, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.